Skip to content

Nasospore Stent For Use in Enodscopic Sinus Surgery

Nasospore Stent For The Use in Endoscopic Sinus Surgery

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00671541
Enrollment
0
Registered
2008-05-05
Start date
2006-03-31
Completion date
2012-02-29
Last updated
2012-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Sinusitis

Brief summary

The purpose of this study is to evaluate a stenting material called Nasopore. This is a synthetic material approved by FDA for use as a stent in postoperative sinus surgery patients. This study will compare the Nasopore stent to other approved stenting materials.

Detailed description

This study will compare other sinus stenting products to the Nasopore stent. The stents will be soaked in antibiotic solutions and be observed for how well they perform. Subjects will have a stent placed in each sinus, stents may be the standard antibiotic saturated materials or the new nasopore material or nasopore stent soaked in antibiotics.

Interventions

DRUGMerogel Nasal Stent and Nasopore Stent

Merogel Nasal Stent and Nasopore Stent

DRUGNasopore Stent and either Gentamycin or Bacitracin

Nasopore Stent with Bacitracin (100,000 units in 10cc(NSS)or Gentamycin(80mg in 10cc NSS)

Sponsors

Lahey Clinic
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Evaluation by Otolaryngologist & determined to need endoscopic sinus surgery * Only subjects with Bilateral disease

Exclusion criteria

* Pediatric subjects(under the age of 18)

Design outcomes

Primary

MeasureTime frame
This study will evaluate the efficacy of nasopore stent soaked in bacitracin in and one stent soaked in gentaymcin antibiotic solutionprospective

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026